Form
SCHEDULE 13G
Passive or exempt beneficial ownership filing.
SHERPA HEALTHCARE FUND II, L.P. - 16 Apr 2026 SCHEDULE 13G Report for Alamar Biosciences, Inc. Common Stock, par value $0.0001 per share (ALMR)
- Filing manager
- SHERPA HEALTHCARE FUND II, L.P.
- Reporting owner
- Daqing Cai
- Beneficially owned shares
- 4,972,134 shares
- Large-stake signal
-
Ownership
7.2%Beneficial ownership of this reported class.
Shares
4,972,134 sharesShares beneficially owned as disclosed.
Event date
16 Apr 2026Date tied to the ownership event or amendment.
Accepted by SEC
02 Jul 2026EDGAR acceptance date.
How to read this large-stake filing
- Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
- Compare this filing with the holder history and issuer page before treating the percentage as a current position.
- Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
- Class ownership
- 7.2%
- Symbol
- ALMR
- Shares outstanding
- 69,057,417 shares
- SEC form
- SCHEDULE 13G
- Accepted by SEC
- 02 Jul 2026, 08:46:06 UTC
- Event date
- 16 Apr 2026
- Source filing
- View source filing
Ownership signal
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Subject security
Names, identifiers, and filing context for this profile.
2 source fields
Source evidence
Original filing metadata and source links for verification.
4 source fields
Key filing fact
SHERPA HEALTHCARE FUND II, L.P. disclosed 7.2% ownership in Alamar Biosciences, Inc. Common Stock, par value $0.0001 per share (ALMR) on 16 Apr 2026.
Key facts
- SHERPA HEALTHCARE FUND II, L.P. filed SCHEDULE 13G for Alamar Biosciences, Inc. Common Stock, par value $0.0001 per share (ALMR).
- Disclosed ownership: 7.2%.
- Date of event: 16 Apr 2026.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 02 Jul 2026, 08:46.
Research use
- This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
- Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.
Evidence
Backed by Schedule 13D/13G
View source filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Disclosed reporting parties (5)
Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares owned | Sole voting power | Shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| SHERPA HEALTHCARE FUND II, L.P. | 5.7% | 3,970,446 | 3,970,446 | 0 | Daqing Cai | Daqing Cai, Director of Sherpa Healthcare Fund II GP, Ltd., the general partner of Sherpa Healthcare Fund II, L.P. | |
| SHERPA HEALTHCARE CO-INVESTMENT FUND, L.P. | 1.4% | 1,001,688 | 1,001,688 | 0 | Daqing Cai | Daqing Cai, Director of Sherpa Healthcare Co-Investment GP Ltd., the general partner of Sherpa Healthcare Co-Investment Fund, L.P. | |
| Sherpa Healthcare Fund II GP, Ltd. | 5.7% | 3,970,446 | 3,970,446 | 0 | Daqing Cai | Daqing Cai, Director | |
| Sherpa Healthcare Co-Investment GP Ltd. | 1.4% | 1,001,688 | 1,001,688 | 0 | Daqing Cai | Daqing Cai, Director | |
| Daqing Cai | 7.2% | 4,972,134 | 0 | 4,972,134 | Daqing Cai | Daqing Cai |
CIK / CUSIP context first